Vı́ctor Agmo Hernández

This researcher studies the biophysical and chemical properties of lipid membranes and nanoscale lipid-based drug carriers, such as liposomes and lipodisks, often for use in delivering cancer drugs or therapeutic peptides. Work combines surface chemistry techniques (like quartz crystal microbalance, neutron reflectometry, and electrochemistry) with biological testing to understand how these membrane structures behave, degrade, or interact with drugs and other molecules. The research sits at the interface of physical chemistry, biochemistry, and pharmaceutical nanotechnology.

Publication output rose from 2017 to a peak around 2022 and has since declined to a lower, steady rate of about 2-4 papers per year in recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026